| HCs | SLE | |
---|---|---|---|
P-SLE | NP-SLE | ||
Fecal samples | 17 | 20 | 20 |
Age, years, mean ± SD | 30.12 ± 14.14 | 34.25 ± 10.54 | 35.95 ± 10.27 |
BMI, kg/m2, mean ± SD | 22.48 ± 2.51 | 22.49 ± 3.39 | 23.16 ± 2.78 |
Disease duration, years, median (IQR) | - | 1.5(0.15–4.7) | 5.5(0.7–10.75) |
SLEDAI, mean ± SD | - | 9.65 ± 4.78 | 6.5 ± 4.51 |
ESR, mm/h, mean ± SD | - | 48.8 ± 28.99 | 31.5 ± 20.68 |
CRP, mg/l, mean ± SD | - | 12.08 ± 25.72 | 9.59 ± 20.63 |
C3, g/l, mean ± SD | - | 0.64 ± 0.24 | 0.76 ± 0.34 |
C4, g/l, mean ± SD | - | 0.10 ± 0.09 | 0.13 ± 0.08 |
Lupus nephritis, n (%) | - | 9(45) | 6(30) |
Positive anti-dsDNA, n (%) | - | 11(55) | 14(70) |
Positive anti-SSA, n (%) | - | 14(70) | 15(75) |
Positive anti-SSB, n (%) | - | 4(20) | 6(30) |
Positive anti-RNP, n (%) | - | 11(55) | 16(80) |
Drugs use | |||
 Hydroxychloroquine, n (%) | - | 15(75) | 18(90) |
 Glucocorticoid, n (%) | - | 18(90) | 17(85) |
 Immunosuppressant, n (%) | - | 10(50) | 6(30) |
 NSAIDs, n (%) | - | 3(15) | 6(30) |